Antibac Soap Decline Likely In Reaction To Triclosan Debate

FDA’s recent proposal to amend the OTC antiseptic drug product monograph could impact sales of antibacterial soaps, according to analysts from market research firm Kline & Company. Firms will “likely choose the path of least resistance” and replace controversial ingredient triclosan, they predict.